Author

Laurentiu M. Pop

The University of Texas Southwestern Medical CenterORCID 0000-0001-8966-8020Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Raquibul HannaniD· 2 shared Adam RusekiD· 1 shared Anthony J. DavisiD· 1 shared Brock J. SishciD· 1 shared Cassandra HamiltoniD· 1 shared Elizabeth M. AlvesiD· 1 shared Eslam A. ElghonaimyiD· 1 shared James BrugarolasiD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Raquibul HannanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewedOct 13, 2025

Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinoma

Katy L. Swancutt, Eslam A. Elghonaimy, James H. Nicholson…·Todd Anthony Aguilera

This study evaluates carbon ion therapy's effectiveness in pancreatic ductal adenocarcinoma, finding that immune stromal components reduce its efficacy in vivo compared to in vitro results.

4 citations

mousebulk RNA-seq

𝕏 PostBluesky

BioinformaticsScience ImmunologyPeer-reviewedFeb 14, 2020

Tumor Neoantigenicity Assessment with CSiN Score Incorporates Clonality and Immunogenicity to Predict Immunotherapy Outcomes

Tianshi Lu, Shidan Wang, Lin Xu…·Tao Wang

The paper introduces the CSiN score to predict immunotherapy outcomes by assessing tumor neoantigen quality through clonality and immunogenicity, showing improved performance over existing methods.

48 citations

humanwhole-exome sequencing

𝕏 PostBluesky